Aurobindo Pharma Limited
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
What Aurobindo files
- Others79
- Updates76
- Investor Meet65
- Important35
- JV/Acquisition25
- Board Meeting11
Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-IV of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company
Aurobindo Pharma Limited has announced participation in one-on-one and group meetings at the J. P. Morgan India Investor Conference in Mumbai, where company officials will interact with investors and analysts to discuss general business perspectives without sharing any unpublished price-sensitive information.
Aurobindo Pharma Limited has announced participation in the Bank of America 2026 Asia Pacific Conference through one-on-one and group meetings in Hong Kong. Discussions will focus on routine business updates with no unpublished price-sensitive information intended for sharing.
Aurobindo Pharma Limited has announced participation in an upcoming group meeting with investors and analysts arranged by Emkay Global in Hyderabad, scheduled to discuss general business updates without sharing any unpublished price-sensitive information.
Aurobindo Pharma Limited will participate in the Kotak Healthcare Forum 2026 through one-on-one and group meetings in Mumbai to discuss general business updates without sharing unpublished price-sensitive information.